In contrast to these studies, mice lacking SIGNR1 exhibited an ameliorated form of murine colitis, with a reduction in the disease severity, colon damage, and levels of the pro-inflammatory cytokines IL-1β, TNF-α, and IL-6 (27). This evidence concerns the gene IL6 and colitis.